LELYSTAD, Netherlands, July 6, 2017 /PRNewswire/ -- Pepscan, the Dutch biotech company specialized in protein mimicry for the discovery of therapeutics peptides, announced today important progress with a drug development program based on its proprietary CLIPS technology. A team...
For more information, please visit
http://www.prnewswire.com/news-releases/[...]lips-technology-632825383.html